Article info
Multiple sclerosis
Original research
Multiple sclerosis: structural and functional integrity of the visual system following alemtuzumab therapy
- Correspondence to Dr Michael Harry Barnett, Brain and Mind Centre, The University of Sydney, Camperdown, NSW 2050, Australia; michael{at}sydneyneurology.com.au
Citation
Multiple sclerosis: structural and functional integrity of the visual system following alemtuzumab therapy
Publication history
- Received January 22, 2021
- Accepted June 2, 2021
- First published June 29, 2021.
Online issue publication
November 16, 2021
Article Versions
- Previous version (29 June 2021).
- Previous version (26 July 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.